D. Wong

Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase Fusions.

Liliana Villafania, M. Ladanyi, A. Drilon, 2019, Cancer research.

Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of “Second Hit” in Germline BRCA1-Associated Pancreatic Ductal Adenocarcinoma

M. Ladanyi, M. Berger, Z. Stadler, 2022, Molecular Diagnosis & Therapy.

Reliable Clinical MLH1 Promoter Hypermethylation Assessment using a High-Throughput Genome-Wide Methylation Array Platform.

Liliana Villafania, M. Ladanyi, M. Arcila, 2019, The Journal of molecular diagnostics : JMD.

Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing

Ahmet Zehir, Donavan T. Cheng, Kenneth Offit, 2017, BMC Medical Genomics.

Reliable Pan-Cancer Microsatellite Instability Assessment by Using Targeted Next-Generation Sequencing Data.

Ahmet Zehir, Sumit Middha, Gowtham Jayakumaran, 2017, JCO precision oncology.

Integrated analysis of cell-free DNA for the early detection of cancer in people with Li-Fraumeni Syndrome

D. Malkin, R. Kim, Y. Sundaravadanam, 2022, medRxiv.

Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing

Donavan T. Cheng, M. Ladanyi, M. Berger, 2017, BMC Medical Genomics.

Genomic Profiling Reveals Germline Predisposition and Homologous Recombination Deficiency in Pancreatic Acinar Cell Carcinoma

M. Ladanyi, M. Berger, J. Reis-Filho, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.